Novartis AG (SWX:NOVN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
126.60
-0.18 (-0.14%)
Jul 31, 2026, 5:30 PM CET

Novartis AG Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7,61611,43511,45913,3937,51712,407
Short-Term Investments
2981,89268011,20915,817
Cash & Short-Term Investments
7,61811,53313,35114,07318,72628,224
Cash Growth
13.16%-13.62%-5.13%-24.85%-33.65%147.49%
Accounts Receivable
9,6368,9377,4237,1078,0668,005
Other Receivables
2181,8961,7082,1401,7351,558
Receivables
9,85410,8339,1319,2479,8019,563
Inventory
6,2206,2695,7235,9137,1756,666
Prepaid Expenses
-1,1539857649111,102
Other Current Assets
3,659672514484297163
Total Current Assets
27,35130,46029,70430,48136,91045,718
Property, Plant & Equipment
12,26712,35210,87310,92412,19513,106
Long-Term Investments
3711,0911,1281,8271,6062,268
Goodwill
26,76725,56724,75623,34129,30129,595
Other Intangible Assets
42,07429,41126,91526,87931,64428,683
Long-Term Accounts Receivable
-52541045970
Long-Term Deferred Tax Assets
5,2775,4384,3594,3093,7393,743
Long-Term Deferred Charges
-----5,499
Other Long-Term Assets
7,9266,4364,3551,9661,9143,035
Total Assets
122,033110,949102,24699,945117,453131,795

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4,2584,4564,5724,9265,1465,553
Accrued Expenses
-5,3624,9885,1745,3875,149
Short-Term Debt
-4,7274,7333,8933,6353,606
Current Portion of Long-Term Debt
9,5888753,4992,2822,2962,689
Current Portion of Leases
274263235230251275
Current Income Taxes Payable
2,3121,9691,5991,8932,5332,415
Current Unearned Revenue
---98123123
Other Current Liabilities
15,3169,6269,0667,8949,28510,398
Total Current Liabilities
31,74827,27828,69226,39028,65630,208
Long-Term Debt
37,48927,93521,36618,43620,24422,902
Long-Term Leases
1,6631,6571,5681,5981,5381,621
Pension & Post-Retirement Benefits
-2,5642,4732,7302,6393,789
Long-Term Deferred Tax Liabilities
5,2923,3972,4192,2482,6863,070
Other Long-Term Liabilities
3,8951,5691,6021,7932,2672,383
Total Liabilities
80,08764,40058,12053,19558,03063,973

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
736766793825890901
Retained Earnings
39,64944,72046,56149,64963,54070,989
Treasury Stock
-49-50-53-41-92-48
Comprehensive Income & Other
1,206694-3,255-3,766-4,996-4,187
Total Common Equity
41,54246,13044,04646,66759,34267,655
Minority Interest
404419808381167
Shareholders' Equity
41,94646,54944,12646,75059,42367,822
Total Liabilities & Equity
122,033110,949102,24699,945117,453131,795

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
49,01435,45731,40126,43927,96431,093
Net Cash (Debt)
-41,396-23,924-18,050-12,366-9,238-2,869
Net Cash Growth
------
Net Cash Per Share
-21.48-12.24-8.87-5.91-4.20-1.27
Filing Date Shares Outstanding
1,9011,9081,9752,0442,1202,235
Total Common Shares Outstanding
1,9011,9081,9752,0442,1202,235
Working Capital
-4,3973,1821,0124,0918,25415,510
Book Value Per Share
21.8624.1822.3022.8328.0030.27
Tangible Book Value
-27,299-8,848-7,625-3,553-1,6039,377
Tangible Book Value Per Share
-14.36-4.64-3.86-1.74-0.764.20
Land
-446376403451492
Buildings
-10,7469,52610,14711,39611,819
Machinery
-10,4539,0469,63011,84213,328
Construction In Progress
-1,8631,6101,2131,1841,508